Deubiquitination of Abelson tyrosine kinase: A novel regulatory mechanism targeting non‐small cell lung cancer glycolysis
Abstract In this commentary, we briefly introduce the importance of metabolic reprogramming in non‐small celllung cancer (NSCLC) and the role of aberrant glycolysis processes intumorigenesis and metastasis. We further summarize the regulation of deubiquitylation modification on glycolysis‐related ki...
Saved in:
Main Authors: | Tong Yu (Author), Shuxia Jiang (Author), Hongli Shan (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis
by: Franziska Paech, et al.
Published: (2017) -
Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
by: Yi-Zheng Fang, et al.
Published: (2023) -
Targeting glycolysis in non-small cell lung cancer: Promises and challenges
by: Jia-Qi Xu, et al.
Published: (2022) -
Deubiquitinating enzymes for targeted cancer therapy
by: Yue Li, et al.
Published: (2023) -
Transformation of adenocarcinoma into small cell lung cancer as one of the mechanisms of acquired resistance to anti-EGFR tyrosine kinase inhibitors
by: O. O. Kovalov, et al.
Published: (2024)